
Tilray TLRY
$ 9.6
-5.42%
Quarterly report 2025-Q3
added 10-09-2025
Tilray Historical Prices 2011-2025 | TLRY
Annual Historical Prices Tilray
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.93 | 3.55 | 7.03 | 8.26 | 17.1 | 70.5 | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 70.5 | 1.93 | 18.1 |
Historical Prices of other stocks in the Drug manufacturers industry
| Issuer | Historical Prices | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Alimera Sciences
ALIM
|
3.97 | - | - | $ 142 M | ||
|
Aerie Pharmaceuticals
AERI
|
7.02 | - | - | $ 754 M | ||
|
Canopy Growth Corporation
CGC
|
1.32 | $ 1.19 | -9.16 % | $ 128 M | ||
|
AcelRx Pharmaceuticals
ACRX
|
0.86 | - | 7.5 % | $ 6.35 M | ||
|
Cronos Group
CRON
|
3.69 | $ 2.66 | -2.92 % | $ 1.44 B | ||
|
Adamis Pharmaceuticals Corporation
ADMP
|
0.12 | - | 0.86 % | $ 117 M | ||
|
Catalent
CTLT
|
60 | - | - | $ 11.5 B | ||
|
Agile Therapeutics
AGRX
|
0.6 | - | 10.11 % | $ 58.2 M | ||
|
DURECT Corporation
DRRX
|
1.21 | - | - | $ 50.1 M | ||
|
Eagle Pharmaceuticals
EGRX
|
26.3 | - | -39.89 % | $ 27.7 M | ||
|
Aurora Cannabis
ACB
|
4.08 | $ 4.49 | -1.75 % | $ 86.3 M | ||
|
Endo International plc
ENDP
|
0.29 | - | - | $ 28.9 M | ||
|
Zomedica Corp.
ZOM
|
0.14 | - | -0.21 % | $ 98 M | ||
|
Evoke Pharma
EVOK
|
0.67 | - | - | $ 36.6 M | ||
|
Calliditas Therapeutics AB (publ)
CALT
|
19.7 | - | -0.1 % | $ 2.03 B | ||
|
HEXO Corp.
HEXO
|
0.71 | - | 2.45 % | $ 38.1 M | ||
|
Zynerba Pharmaceuticals
ZYNE
|
0.44 | - | - | $ 55.5 M | ||
|
Emergent BioSolutions
EBS
|
2.71 | $ 12.43 | -1.58 % | $ 636 M | ||
|
Athenex
ATNX
|
1.75 | - | -23.39 % | $ 1.76 M | ||
|
Avadel Pharmaceuticals plc
AVDL
|
7.54 | $ 21.59 | 0.05 % | $ 2.05 B | ||
|
OrganiGram Holdings
OGI
|
1.58 | $ 1.79 | 1.7 % | $ 402 M | ||
|
Organogenesis Holdings
ORGO
|
3.15 | $ 5.28 | -10.14 % | $ 695 M | ||
|
Evolus
EOLS
|
14.3 | $ 6.9 | 0.73 % | $ 428 M | ||
|
Harrow Health
HROW
|
10.7 | $ 50.09 | -0.14 % | $ 1.63 B | ||
|
China Pharma Holdings
CPHI
|
0.26 | $ 1.29 | -2.65 % | $ 22.5 M | ||
|
Rockwell Medical
RMTI
|
1.52 | $ 0.86 | 6.83 % | $ 20.1 M | ||
|
Neoleukin Therapeutics
NLTX
|
3.49 | - | - | $ 193 M | ||
|
Sonoma Pharmaceuticals
SNOA
|
2.95 | $ 3.61 | -0.82 % | $ 4.48 M | ||
|
Bausch Health Companies
BHC
|
9.27 | $ 7.2 | 0.07 % | $ 2.63 B | ||
|
Lannett Company
LCI
|
0.57 | - | 1.15 % | $ 7.11 M | ||
|
Cumberland Pharmaceuticals
CPIX
|
6.3 | $ 4.12 | -1.9 % | $ 57.9 M | ||
|
Veru
VERU
|
0.8 | $ 2.4 | 2.56 % | $ 324 M | ||
|
Pacira BioSciences
PCRX
|
25.5 | $ 26.51 | 1.88 % | $ 1.23 B | ||
|
Sundial Growers
SNDL
|
1.45 | $ 1.73 | -2.26 % | $ 3.37 M | ||
|
cbdMD
YCBD
|
0.39 | $ 1.68 | 5.66 % | $ 7.25 M | ||
|
PetIQ
PETQ
|
13.6 | - | 1.64 % | $ 400 M | ||
|
Jupiter Wellness
JUPW
|
1.52 | - | - | $ 33.6 M | ||
|
Perrigo Company plc
PRGO
|
28.8 | $ 13.82 | 0.62 % | $ 1.9 B | ||
|
ProPhase Labs
PRPH
|
8.24 | $ 0.52 | -15.45 % | $ 8.24 M | ||
|
Radius Health
RDUS
|
8.32 | - | - | $ 1.42 B | ||
|
Recro Pharma
REPH
|
1.4 | - | -4.76 % | $ 65.3 M | ||
|
Relmada Therapeutics
RLMD
|
5.37 | $ 4.51 | -1.96 % | $ 136 M | ||
|
OptiNose
OPTN
|
1.71 | - | - | $ 1.08 B | ||
|
Assertio Holdings
ASRT
|
0.93 | $ 9.94 | 0.42 % | $ 706 M | ||
|
PLx Pharma
PLXP
|
5.05 | - | -27.8 % | $ 2.56 M | ||
|
Solid Biosciences
SLDB
|
5.53 | $ 5.84 | -1.02 % | $ 238 M | ||
|
SCYNEXIS
SCYX
|
1.47 | $ 0.59 | -1.34 % | $ 28.2 M | ||
|
Tricida
TCDA
|
7.96 | - | - | $ 3.25 M | ||
|
TherapeuticsMD
TXMD
|
2.29 | $ 1.74 | 2.35 % | $ 18.2 M |